Merrimack Pharmaceuticals Inc insider trading alert for grant of stock option (right to buy) by John Mendelsohn, the corporate stakeholder, on December 7, 2017. This event was filed by Merrimack Pharmaceuticals with SEC on 2017-09-15. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on December 7, 2017 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 0.95% . The trading delta at closing time when the story was published against the current closing price is 0.67% .

Similar stores for Merrimack Pharmaceuticals

Merrimack Pharmaceuticals logo Northern Trust Corp grew its stake in Merrimack Pharmaceuticals, Inc. by 2.0 percent in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission.

Operating Margin

Operating Margin Comparative Analysis

Operating Margin

Merrimack Pharmaceuticals Comparables

Merrimack Pharmaceuticals is currently under evaluation in operating margin category among related companies. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.